CN Stock MarketDetailed Quotes
603077 Sichuan Hebang Biotechnology
- 2.29
- -0.03-1.29%
Market Closed Dec 13 15:00 CST
20.22BMarket Cap41.64P/E (TTM)
2.38High2.28Low2.14MlotVolume2.32Open2.32Pre Close493.98MTurnover2.42%Turnover Ratio15.79P/E (Static)8.83BShares2.6052wk High1.09P/B20.22BFloat Cap1.5952wk Low2.55Limit Up8.83BShs Float5.03Historical High2.09Limit Down4.31%Amplitude0.63Historical Low0.02Dividend TTM2.31Avg Price1.27MlotAsk0.87%Div YieldTTM100Lot Size818.37KlotBid
Sichuan Hebang Biotechnology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 5.89%6.81B | 18.53%4.85B | -16.51%2B | -32.33%8.82B | -38.68%6.43B | -45.31%4.09B | -22.41%2.39B | 30.55%13.04B | 47.23%10.49B | 89.36%7.48B |
| Operating revenue | 5.89%6.81B | 18.53%4.85B | -16.51%2B | -32.33%8.82B | -38.68%6.43B | -45.31%4.09B | -22.41%2.39B | 30.55%13.04B | 47.23%10.49B | 89.36%7.48B |
| Other operating revenue | ---- | 18.14%70.32M | ---- | 19.88%117.15M | ---- | 8.31%59.52M | ---- | 63.81%97.73M | ---- | 243.02%54.95M |
| Total operating cost | 24.50%6.55B | 36.67%4.6B | 1.40%1.94B | -14.37%7.33B | -19.11%5.26B | -22.98%3.37B | 3.61%1.92B | 32.93%8.55B | 36.81%6.5B | 51.63%4.37B |
| Operating cost | 24.52%6.08B | 37.82%4.31B | 1.56%1.8B | -9.12%6.77B | -14.28%4.89B | -19.09%3.12B | 9.44%1.77B | 27.27%7.45B | 33.37%5.7B | 48.77%3.86B |
| Operating tax surcharges | 19.57%51.87M | 32.57%38.62M | -16.08%11.66M | -41.90%66.25M | -53.55%43.38M | -57.75%29.13M | -39.25%13.89M | 14.57%114.02M | 36.17%93.4M | 86.60%68.96M |
| Operating expense | 31.99%54.2M | 21.74%33.22M | 18.13%16.37M | 13.49%59.56M | 9.73%41.07M | 30.47%27.29M | 15.54%13.86M | 0.76%52.48M | 0.23%37.42M | -8.33%20.91M |
| Administration expense | 13.49%304.67M | 12.76%195.64M | 0.38%106.56M | -51.07%413.4M | -56.89%268.46M | -55.32%173.5M | -42.13%106.16M | 171.16%844.97M | 122.30%622.69M | 140.55%388.35M |
| Financial expense | 552.50%32.11M | 473.07%15.03M | -13.02%4.25M | -234.72%-32.5M | -127.29%-7.1M | -124.09%-4.03M | -37.50%4.89M | -71.42%24.13M | -63.02%26M | -67.43%16.72M |
| -Interest expense (Financial expense) | 43.66%60.44M | 36.76%37.1M | 14.01%16.28M | -52.61%24.37M | -8.45%42.07M | -10.58%27.13M | -3.92%14.28M | -33.90%51.43M | -26.92%45.96M | -30.22%30.34M |
| -Interest Income (Financial expense) | 30.61%-30.23M | 35.04%-18M | 15.26%-9.14M | -166.00%-60.35M | -189.10%-43.56M | -244.08%-27.7M | -197.76%-10.79M | -142.46%-22.69M | -164.56%-15.07M | -262.82%-8.05M |
| Research and development | -21.38%22.52M | -18.31%14.79M | -8.37%8.35M | -30.30%47.35M | 17.16%28.64M | 6.84%18.11M | 18.81%9.11M | 103.92%67.93M | 2.14%24.45M | 5.01%16.95M |
| Credit Impairment Loss | 56.89%-9.32M | 48.89%-5.92M | -60.70%-14.53M | -5.49%-13.46M | -7.75%-21.62M | 56.96%-11.58M | 55.36%-9.04M | -517.36%-12.76M | -637.44%-20.07M | -2,263.89%-26.92M |
| Asset Impairment Loss | ---6.53M | 86.16%-3.93M | ---- | 54.53%-36.75M | ---- | ---28.38M | ---- | ---80.83M | ---- | ---- |
| Other net revenue | -109.03%-3.36M | -80.46%1.54M | -8,216.90%-11.32M | 1,572.91%43.31M | -29.12%37.16M | 682.60%7.87M | 102.56%139.49K | -107.47%-2.94M | 218.24%52.43M | -91.35%1.01M |
| Invest income | -102.73%-1.26M | -100.71%-300.2K | -111.47%-735.65K | 244.55%75.22M | 165.99%46.11M | 228.57%42.39M | 81.30%6.41M | -19.00%21.83M | 58.92%17.33M | 66.58%12.9M |
| -Including: Investment income associates | -101.02%-463.14K | ---- | ---- | 160.42%51.22M | 152.15%45.32M | 199.51%39.91M | -25.01%3.88M | 53.64%19.67M | 114.11%17.97M | 142.11%13.32M |
| Asset deal income | -102.67%-23.7K | -907.25%-36.24K | -1,612.79%-46.77K | -97.82%808.18K | -97.60%889.14K | 102.50%4.49K | 132.05%3.09K | 3,661.36%37.1M | 1,683.07%36.99M | -109.04%-179.66K |
| Other revenue | 16.87%13.78M | 115.37%11.72M | 44.26%3.99M | -44.83%17.49M | -35.13%11.79M | -64.20%5.44M | -75.48%2.76M | 204.12%31.71M | 192.46%18.17M | 401.39%15.2M |
| Operating profit | -78.50%260.3M | -66.31%245.77M | -90.86%43.61M | -65.59%1.54B | -70.05%1.21B | -76.51%729.55M | -61.21%477.21M | 24.79%4.48B | 69.15%4.04B | 188.51%3.11B |
| Add:Non operating Income | 66,746.14%27.9K | -50.23%17.36 | -49.89%4.63 | 5,409.45%3.22M | -99.70%41.74 | -99.73%34.88 | -99.59%9.24 | -98.06%58.36K | -99.55%14.1K | -99.57%12.88K |
| Less:Non operating expense | 8.16%826.18K | -37.43%446.44K | -99.42%3.6K | 240.77%9.04M | -69.37%763.88K | -71.08%713.46K | -74.55%622.4K | -83.11%2.65M | -15.04%2.49M | 1,264.34%2.47M |
| Total profit | -78.55%259.5M | -66.34%245.32M | -90.85%43.61M | -65.70%1.54B | -70.05%1.21B | -76.52%728.84M | -61.18%476.58M | 25.16%4.48B | 69.03%4.04B | 187.53%3.1B |
| Less:Income tax cost | -67.33%63.96M | -54.43%57.27M | -82.69%16.47M | -61.51%257.27M | -67.62%195.76M | -72.84%125.69M | -47.88%95.12M | 21.10%668.32M | 62.85%604.65M | 171.25%462.86M |
| Net profit | -80.72%195.54M | -68.82%188.05M | -92.88%27.14M | -66.44%1.28B | -70.47%1.01B | -77.16%603.14M | -63.50%381.46M | 25.90%3.81B | 70.17%3.43B | 190.59%2.64B |
| Net profit from continuing operation | -80.72%195.54M | -68.82%188.05M | -92.88%27.14M | -66.44%1.28B | -70.47%1.01B | -77.16%603.14M | -63.50%381.46M | 25.90%3.81B | 70.17%3.43B | 190.59%2.64B |
| Less:Minority Profit | -418.86%-25.78M | 68.47%-4.22M | 82.46%-2.65M | -232.49%-4.54M | -172.37%-4.97M | -318.81%-13.39M | -728.96%-15.1M | -57.29%3.43M | -32.89%6.87M | 274.75%6.12M |
| Net profit of parent company owners | -78.28%221.32M | -68.81%192.27M | -92.49%29.79M | -66.29%1.28B | -70.27%1.02B | -76.60%616.53M | -61.97%396.56M | 26.12%3.81B | 70.69%3.43B | 188.80%2.63B |
| Earning per share | ||||||||||
| Basic earning per share | -77.05%0.0268 | -67.33%0.0231 | -92.09%0.0036 | -66.32%0.1474 | -70.39%0.1168 | -76.59%0.0707 | -62.08%0.0455 | 22.33%0.4377 | 65.97%0.3945 | 179.63%0.302 |
| Diluted earning per share | -77.05%0.0268 | -67.33%0.0231 | -92.09%0.0036 | -66.32%0.1474 | -70.39%0.1168 | -76.59%0.0707 | -62.08%0.0455 | 22.33%0.4377 | 65.97%0.3945 | 179.63%0.302 |
| Other composite income | -53,470.20%-33.08M | -216.28%-16.37M | 113.25%1.49M | -26.75%31.69M | -100.12%-61.74K | -44.33%14.07M | -1,834.74%-11.23M | 511.82%43.26M | 18,979.31%53.15M | 1,118.43%25.28M |
| Other composite income of parent company owners | -440.83%-31.65M | -323.96%-16.53M | 113.47%1.31M | -7.57%28.96M | -114.88%-5.85M | -61.02%7.38M | -1,159.94%-9.74M | 525.04%31.34M | 10,442.43%39.34M | 1,621.61%18.93M |
| Other composite income of minority owners | -124.58%-1.42M | -97.56%163.45K | 111.84%176.62K | -77.17%2.72M | -58.06%5.79M | 5.43%6.69M | -449.41%-1.49M | 480.71%11.93M | 2,209.11%13.81M | 612.79%6.35M |
| Total composite income | -83.98%162.46M | -72.18%171.68M | -92.27%28.63M | -65.99%1.31B | -70.92%1.01B | -76.85%617.22M | -64.60%370.23M | 27.77%3.85B | 72.82%3.49B | 194.17%2.67B |
| Total composite income of parent company owners | -81.28%189.67M | -71.83%175.74M | -91.96%31.1M | -65.81%1.31B | -70.77%1.01B | -76.49%623.91M | -62.94%386.82M | 27.47%3.84B | 72.62%3.47B | 191.27%2.65B |
| Total composite income of minority owners | -3,409.64%-27.2M | 39.40%-4.06M | 85.10%-2.47M | -111.86%-1.82M | -96.02%821.99K | -153.70%-6.7M | -879.19%-16.59M | 213.48%15.36M | 115.89%20.67M | 363.06%12.47M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Sichuan Huaxin (Group) Accounting Firm (Special General Partnership) | -- | -- | -- | Sichuan Huaxin (Group) Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
